Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,

Published bySharyl Carr Modified over 5 years ago

Similar presentations

Presentation on theme: "Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,"— Presentation transcript:

1 Prognosis and survival after resection for bronchogenic carcinoma based on the TNM-staging classification: the Japanese experience  Tsuguo Naruke, MD, Ryosuke Tsuchiya, MD, Haruhiko Kondo, MD, Hisao Asamura, MD  The Annals of Thoracic Surgery  Volume 71, Issue 6, Pages (June 2001) DOI: /S (00)

2 Fig 1 Survival rates for 2,819 patients M0 group after resection of lung cancer according to pathological T (includes 3 patients with TX and 9 patients with T0). Differences between groups: T1 versus T2, p < 0.01; T2 versus T3, p < 0.01; T3 versus T4, p < 0.01. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

3 Fig 2 Survival rates for 2,819 patients M0 group after resection of lung cancer, according to pathological N. Differences between groups: N0 versus N1, p < 0.01; N1 versus N2, p < 0.01; N2 versus N3, p < 0.01. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

4 Fig 3 Survival rates for 3,043 patients after resection of lung cancer according to postoperative stage (includes 1 patient with occult carcinoma and 6 patients with stage 0). Differences between groups: stage IA versus stage IB, p < 0.01; stage IB versus stage IIA, not significant; stage IIA versus stage IIB, p < 0.01; stage IIB versus stage IIIA, p < 0.01; stage IIIA versus stage IIIB, p < 0.01; stage IIIB versus stage IV, p < 0.01. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

5 Fig 4 Survival rates for 3,043 patients after resection of lung cancer according to clinical stage (includes 3 patients with occult carcinoma). Differences between groups: stage IA versus stage IB, p < 0.01; stage IB versus stage IIA, NS; stage IIA versus stage IIB, NS; stage IIB versus stage IIIA, p < 0.01; stage IIIA versus stage IIIB, p < 0.01; stage IIIB versus stage IV, NS. (NS = not significant.) The Annals of Thoracic Surgery  , DOI: ( /S (00) )

6 Fig 5 Survival rates for 3,043 patients after resection of lung cancer according to satellite nodule(s). Differences between groups: pm0 versus pm1, pm1 versus pm2, p < (pm0 = no separate tumor nodule(s); pm1 = separate tumor nodule(s) in same lobe; pm2 = separate tumor nodule(s) in different lobe.) The Annals of Thoracic Surgery  , DOI: ( /S (00) )

Download ppt "Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Minimally invasive esophagectomy

Minimally invasive esophagectomy
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis  Amgad El-Sherif, MD, William E. Gooding, MS,
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers  Hisao Asamura, MD, Tomoyuki Goya, MD, Yoshihiko Koshiishi, MD, Yasunori.

A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers  Hisao Asamura, MD, Tomoyuki Goya, MD, Yoshihiko Koshiishi, MD, Yasunori.
Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences  Jean Deslauriers, MD, Jocelyn Grégoire,

Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences  Jean Deslauriers, MD, Jocelyn Grégoire,
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients  Elizabeth A. David, MD, Stina W. Andersen, PhD,

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients  Elizabeth A. David, MD, Stina W. Andersen, PhD,
Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,
Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancer  Yukiko Haga, MD, Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi.

Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancer  Yukiko Haga, MD, Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi.
Surgical Management of Recurrent Thymic Epithelial Tumors: A Retrospective Analysis Based on the Japanese Nationwide Database  Tetsuya Mizuno, MD, Meinoshin.

Surgical Management of Recurrent Thymic Epithelial Tumors: A Retrospective Analysis Based on the Japanese Nationwide Database  Tetsuya Mizuno, MD, Meinoshin.
Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 
Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion  Kenji Suzuki, MD, Hisao.

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion  Kenji Suzuki, MD, Hisao.

Similar presentations

Ads by Google